Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human embryonic germ cells for future neuronal replacement therapy.

Lee Turnpenny1, Iain T Cameron, Cosma M Spalluto

  • 1Human Genetics Division, University of Southampton, Southampton SO16 6YD, UK.

Brain Research Bulletin
|December 6, 2005
PubMed
Summary

Human embryonic germ cells (hEGCs) show promise for cell replacement therapies. These cells possess self-renewal, differentiation, and lack of tumor-forming potential, crucial for treating diseases like Parkinson's and Alzheimer's.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Proactive case-finding and risk-stratification in people at risk of chronic liver disease in Greater Manchester: a cost-effectiveness analysis.

BMJ public health·2026
Same author

A cell atlas of the developing human outflow tract of the heart and its adult aortic valve derivatives.

eLife·2026
Same author

Predicting aflatoxin M<sub>1</sub> in raw milk using machine learning and basic measurements.

Current research in food science·2026
Same author

Residual lung abnormality following COVID-19 hospitalisation is characterised by biomarkers of epithelial injury.

EBioMedicine·2026
Same author

EVC protein regulates Sonic hedgehog signaling during human intervertebral disc development and degeneration.

iScience·2026
Same author

Metaplastic Barrett's oesophagus represents reversion to a developmental-like epithelial cell state.

Development (Cambridge, England)·2025

Area of Science:

  • Regenerative Medicine
  • Stem Cell Biology
  • Developmental Biology

Background:

  • Stem cell therapy holds significant potential for treating human diseases through cellular replacement.
  • Key requirements for effective stem cell therapies include self-renewal, differentiation into normal cell types, and lack of tumorogenicity.
  • Human embryonic stem cells (hESCs) are a well-studied source, but other cell types may offer complementary advantages.

Purpose of the Study:

  • To investigate human embryonic germ cells (hEGCs) as a potential source for cell replacement therapies.
  • To evaluate the key characteristics of hEGCs relevant to therapeutic applications.
  • To explore the potential of hEGCs alongside hESCs for treating degenerative diseases.

Main Methods:

  • Characterization of human embryonic germ cells (hEGCs).

Related Experiment Videos

  • Assessment of self-renewal capacity.
  • Evaluation of differentiation potential into various human cell types.
  • Analysis of tumorogenicity in vitro and/or in vivo models.

    • Main Results:

    • Human embryonic germ cells (hEGCs) demonstrate robust self-renewal capabilities.
    • hEGCs exhibit the potential to differentiate into multiple physiologically normal human cell types.
    • Preliminary data suggests a low risk of tumorogenicity associated with hEGCs.

    Conclusions:

    • Human embryonic germ cells (hEGCs) represent a promising cell source for regenerative medicine.
    • hEGCs possess the essential characteristics required for therapeutic cell replacement strategies.
    • Further research into hEGCs could lead to novel treatments for neurodegenerative diseases and stroke recovery.